Armistice Capital, Llc Brickell Biotech, Inc. (BBI) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Brickell Biotech, Inc.. Currently has a direct ownership of 2.17 Million shares of BBI, which is worth approximately $3.82 Million. The most recent transaction as insider was on Jan 10, 2019, when has been sold 2,190,500 shares (Common Stock) at a price of $0.88 per share, resulting in proceeds of $1,927,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.17M

0% 3M change

0% 12M change

Total Value Held $3.82 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2019	SELL Open market or private sale	$1,927,640 $0.88 p/Share	2,190,500 Reduced 50.24%	2,170,000 Common Stock
Jun 28 2018	BUY Open market or private purchase	$1,531,909 $1.2 p/Share	1,276,591 Added 22.65%	4,360,500 Common Stock
Jun 27 2018	BUY Open market or private purchase	$39,397 $1.23 p/Share	32,030 Added 1.03%	3,083,909 Common Stock
Jun 26 2018	BUY Open market or private purchase	$11,288 $1.24 p/Share	9,103 Added 0.3%	3,051,879 Common Stock
Jun 25 2018	BUY Open market or private purchase	$13,447 $1.26 p/Share	10,672 Added 0.35%	3,042,776 Common Stock
Jun 22 2018	BUY Open market or private purchase	$18,150 $1.25 p/Share	14,520 Added 0.48%	3,032,104 Common Stock
Jun 21 2018	BUY Open market or private purchase	$175 $1.25 p/Share	140 Added 0.0%	3,017,584 Common Stock
Jun 20 2018	BUY Open market or private purchase	$4,702 $1.27 p/Share	3,702 Added 0.12%	3,017,444 Common Stock
Jun 18 2018	BUY Open market or private purchase	$16,490 $1.2 p/Share	13,742 Added 0.45%	3,013,742 Common Stock
Jun 14 2018	BUY Open market or private purchase	$33,468 $1.15 p/Share	29,103 Added 0.96%	3,000,000 Common Stock
Jun 13 2018	BUY Open market or private purchase	$154,015 $1.06 p/Share	145,297 Added 4.66%	2,970,897 Common Stock
Jun 12 2018	BUY Open market or private purchase	$181,998 $1.16 p/Share	156,895 Added 5.26%	2,825,600 Common Stock
Jun 11 2018	BUY Open market or private purchase	$442,446 $1.2 p/Share	368,705 Added 12.14%	2,668,705 Common Stock
Jan 22 2018	BUY Open market or private purchase	$144,000 $1.44 p/Share	100,000 Added 4.17%	2,300,000 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL